Additionally, acute intravenous insulin administration decreases soluble Aß40 and Aß42 levels, reduces the soluble/insoluble Aß42 ratio, decreases BACE1 expression and increases X11α in HFD-fed 3xTg-AD mice [279]. Here, BACE1 is linked to Alzheimer disease.